載入...
BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple Myeloma
The treatment of multiple myeloma (MM) has entered into a new era of immunotherapy. Novel immunotherapies will significantly improve patient outcome via simultaneously targeting malignant plasma cell (PC) and reversing immunocompromised bone marrow (BM) microenvironment. B-cell maturation antigen (B...
Na minha lista:
| 發表在: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7352710/ https://ncbi.nlm.nih.gov/pubmed/32516895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12061473 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|